Trending Stories on Eyewire+
Aldeyra Resubmits NDA for Topical Ocular Reproxalap for Dry Eye Disease
Aldeyra Therapeutics announced the resubmission of a new drug application (NDA) to the FDA?for its investigational topical drug,?reproxalap, which is intended to treat the signs and symptoms of... Read More
Novaliq and Laboratoires Théa Announce EU Approval for Vevizye for Dry Eye Disease
Novaliq and Laboratoires Théa?announced the European Commission’s approval of Vevizye?(ciclosporin 0.1% eye drops solution)?for the treatment of moderate to severe dry eye disease (DED) in adults unresponsive to tear substitutes. Vevizye?is based on Novaliq’s proprietary EyeSol?water-free technology, making it the only... Read More
After Shortage, Harrow Announces Relaunch of Triesence
Harrow?has officially relaunched Triesence?(triamcinolone acetonide injectable suspension) 40 mg/mL, a preservative-free synthetic corticosteroid. Triesence is approved by the FDA?for use in visualizing tissues during vitrectomy and treating ocular inflammatory conditions that do not respond to... Read More
EyewireTV | 10.02.2024
Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.?Click here to check it out!
Latest In Podcasts
领英推荐
Little Eyes - Big Topics: An AAPOS Podcast
In this episode, cohosts Jennifer Galvin, MD, and Christine Law, MD, invite a panel of pediatric ophthalmology experts to discuss approaches to managing retinopathy of prematurity (ROP). Gil Binenbaum, MD, MSCE; Emily McCourt, MD; and Jennifer Jung, MD, provide insights on comprehensive ROP screening and treatment approaches at their respective children’s hospitals. Click here to catch the latest episode.
The MOD Pod
In this special episode of The MOD Pod, Cecelia Koetting, OD, FAAO, Dipl ABO, interviews a diverse group of attendees from MOD Live 2024. She speaks with program chairs, faculty, newcomers, and returning attendees, capturing a wide range of perspectives. Catch the latest episode here!
Eyewire News: The Podcast
Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe. Catch the latest episodes here!
Latest in Subspecialties:
Thank you for reading! We'll be back next week with another edition of?Eyewire+ Weekly Digest. For the most up to date news, please visit us at Eyewire+ .